Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Ifosfamide Plus Paclitaxel in Chemotherapy-Naive Patients With Newly Diagnosed Stage I-IV, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus, Fallopian Tube, Peritoneum or Ovary

NCT00954174 is registered in ClinicalTrials.gov with GOG Foundation as lead sponsor.

NCT NCT00954174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00954174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Ifosfamide Plus Paclitaxel in Chemotherapy-Naive Patients With Newly Diagnosed Stage I-IV, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus, Fallopian Tube, Peritoneum or Ovary
Lead sponsor
GOG Foundation
Phase
Phase 3
Overall status
Unknown status
Start date
August 17, 2009
Completion date
Not reported
Enrollment
637 (actual)
Sites
538

Conditions

As the registry lists them; a condition with its own page is linked.

mixed mesodermal (mullerian) tumor, ovarian carcinosarcoma, recurrent fallopian tube carcinoma, recurrent ovarian carcinoma, recurrent primary peritoneal carcinoma, stage i ovarian cancer ajcc v6 and v7, stage ia fallopian tube cancer ajcc v6 and v7, stage ia ovarian cancer ajcc v6 and v7, stage ia uterine sarcoma ajcc v7, stage ib fallopian tube cancer ajcc v6 and v7, stage ib ovarian cancer ajcc v6 and v7, stage ib uterine sarcoma ajcc v7, stage ic fallopian tube cancer ajcc v6 and v7, stage ic ovarian cancer ajcc v6 and v7, stage ic uterine sarcoma ajcc v7, stage ii ovarian cancer ajcc v6 and v7, stage iia fallopian tube cancer ajcc v6 and v7, stage iia ovarian cancer ajcc v6 and v7, stage iia uterine sarcoma ajcc v7, stage iib fallopian tube cancer ajcc v6 and v7, stage iib ovarian cancer ajcc v6 and v7, stage iib uterine sarcoma ajcc v7, stage iic fallopian tube cancer ajcc v6 and v7, stage iic ovarian cancer ajcc v6 and v7, stage iiia fallopian tube cancer ajcc v7, stage iiia ovarian cancer ajcc v6 and v7, stage iiia primary peritoneal cancer ajcc v7, stage iiia uterine sarcoma ajcc v7, stage iiib fallopian tube cancer ajcc v7, stage iiib ovarian cancer ajcc v6 and v7, stage iiib primary peritoneal cancer ajcc v7, stage iiib uterine sarcoma ajcc v7, stage iiic fallopian tube cancer ajcc v7, stage iiic ovarian cancer ajcc v6 and v7, stage iiic primary peritoneal cancer ajcc v7, stage iiic uterine sarcoma ajcc v7, stage iv fallopian tube cancer ajcc v6 and v7, stage iv ovarian cancer ajcc v6 and v7, stage iv primary peritoneal cancer ajcc v7, stage iva uterine sarcoma ajcc v7, stage ivb uterine sarcoma ajcc v7, uterine carcinosarcoma